UK Spy Chief Warns of Growing Threats From Russia and China Geopolitical Risks Loom for Global Markets Federal Reserve Chair Powell Vows Not to Be Shadow Chair as Historic Meeting with Former Chair Looms PutinXi Talks Set to Revive Power of Siberia 2 Pipeline Amid Geopolitical Tensions Starmer Urges TNT Sports to Offer Champions League Final FreetoAir in Potential Shift for Sports Broadcasting US Seeks to Expand American AI Integration in Asia Following TrumpXi Meeting Compass COMP Stock Under 15 Market Perspectives and Key Considerations ASPN Q1 2026 Earnings EPS Misses Estimates as Losses Narrow but Surprise Negative CBRL Q1 2026 Earnings Significant EPS Beat Surprises Market Solid Power Q1 2026 Earnings EPS Beat Drives 3 Stock Uplift Amid PreRevenue Phase DOC Q1 2026 Earnings Massive EPS Beat of 515 Surprises Analysts NE Q1 2026 Earnings EPS Beats Estimates by 301 Stock Declines Atlanticus Holdings Senior Notes ATLCL Q1 2026 Earnings EPS Surges Past Estimates with 258 Beat Atea Pharmaceuticals AVIR Shows Modest Uptick Holding Above Key Support BOK Financial Slips 15 as Regional Banking Sector Faces Renewed Headwinds Liberty Global LBTYA Faces Slight Decline as Stock Tests Key Resistance Levels KORE Group Holdings Inc KORE Holds Steady at 918 as Traders Eye Key Levels Ecolab ECL Holds Near Resistance as Modest Gains Continue The Rise of HALO Stocks Investing in What Artificial Intelligence Cannot Replace Sensei Biotherapeutics Inc SNSE Q1 2026 Earnings Deep EPS Miss Reflects Heavy RD Investment and PreRevenue Status Goosehead Insurance GSHD Surges 45 Closing In on Key Resistance at 4389 Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status HTBK Q4 2025 Earnings Slight EPS Miss Amid Stable Performance OCS Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investments Genie Energy Ltd GNE Q1 2026 Earnings EPS Misses Estimates as Revenue Data Remain Unavailable LNC Q1 2026 Earnings Lincoln National Tops EPS Estimates Amid Steady Operational Progress Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady PECO Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds